WHO ICTRP trial
Does combined doxycycline and autologous blood patch more effective autologous…
PACTR202505753650802 · Pan African Clinical Trials Registry (PACTR) · Recruiting
Key facts
| Trial ID | PACTR202505753650802 |
|---|---|
| Public title | Does combined doxycycline and autologous blood patch more effective autologous blood patch alone for management of persistent air leak in patients with secondary spontaneous pneumothorax : A randomized control trial |
| Scientific title | Efficacy of combined doxycycline and autologous blood patch versus autologous blood patch alone for management of persistent air leak in patients with secondary spontaneous pneumothorax : A randomized control trial |
| Primary sponsor | king Saud medical city |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase-0 |
| Countries | Egypt;Saudi Arabia |
| Conditions | Respiratory;Respiratory |
| Interventions | Autologous blood patch pleurodesis.;autologous blood patch pleurodesis with doxycycline |
| Registration date | Jun 5, 2025 |
| Target size | 60 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: